{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:34:07Z","timestamp":1776875647709,"version":"3.51.2"},"reference-count":43,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T00:00:00Z","timestamp":1404864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Therapeutics"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The systematic review and meta\u2010analysis are to evaluate the effect of t Telmisartan on atrial fibrillation (<jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>) recurrences in hypertensive patients with paroxysmal <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched. Random controlled trials (<jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>s) were conducted in which telmisartan was compared to other antihypertensive drugs for <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content> recurrences prevention in hypertensive patients with paroxysmal <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>. A systematic review and meta\u2010analysis based on aggregate data extracted from the included studies were carried out to assess the telmisartan in preventing <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content> relapse. The efficacy outcome was the incidence of <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content> recurrences. Hazard ratios (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>s) were calculated from published summary statistics and combined to give pooled estimates of efficacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This meta\u2010analysis comprised four studied including 1050 hypertensive patients (537 men and 513 women; mean age 63; mean blood pressure (<jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content>) 156\/94\u00a0mmHg). With the similar <jats:styled-content style=\"fixed-case\">BP<\/jats:styled-content> control, the <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content> recurrences rate was significantly lower in the telmisartan\u2010treated patients than in the other antihypertensive drugs\u2010treated patients (HR 0.54, CI 0.34\u20130.86, <jats:italic>P\u00a0<\/jats:italic>&lt;\u00a00.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this review and meta\u2010analysis indicate that telmisartan seems to be more effective than other antihypertensive drugs in preventing <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content> recurrences among hypertensive patients with paroxysmal AF.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1755-5922.12073","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T07:49:09Z","timestamp":1395301749000},"page":"184-188","source":"Crossref","is-referenced-by-count":19,"title":["Effect of Telmisartan on Atrial Fibrillation Recurrences in Patients with Hypertension: A Systematic Review and Meta\u2010Analysis"],"prefix":"10.1111","volume":"32","author":[{"given":"Gaofeng","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery Zhongnan Hospital of Wuhan University Wuhan Hubei China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery Zhongnan Hospital of Wuhan University Wuhan Hubei China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery Zhongnan Hospital of Wuhan University Wuhan Hubei China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.06.080"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00583-9"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01253-6"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140263.20897.42"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01236-6"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq278"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.065"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.110775"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.830042"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2011.105"},{"key":"e_1_2_7_12_1","first-page":"21","article-title":"Mechanisms of atrial remodelling and clinical relevance","volume":"20","author":"Nattel S","year":"2005","journal-title":"Curr Opin Cardiol"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328338c20e"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.026"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.03.019"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.137760"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jeq176"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000254322.96189.85"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.10.1242"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/1074248410395018"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.21994"},{"key":"e_1_2_7_22_1","first-page":"496","article-title":"A multicenter randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients. Journal of the Renin\u2010Angiotensin\u2010Aldosterone","volume":"13","author":"Galzerano D","year":"2012","journal-title":"System"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.202309"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.10.1062"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.01.006"},{"key":"e_1_2_7_26_1","first-page":"643","article-title":"Effects of losartan on acute atrial electrical remodeling","volume":"117","author":"Li Y","year":"2004","journal-title":"Chin Med J"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000137118.47943.5C"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-005-0571-2"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/hy0302.105683"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960280609"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000022665.18619.83"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.11.070"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005283284"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.09.033"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.10.068"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euq439"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.111.965178"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805710"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2008.00839.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2009.09.016"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2011.09.004"},{"key":"e_1_2_7_42_1","first-page":"41","article-title":"Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers","volume":"25","author":"Kakuta H","year":"2005","journal-title":"Int J Clin Pharmacol Res"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283522a51"}],"container-title":["Cardiovascular Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1755-5922.12073","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1755-5922.12073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T16:21:36Z","timestamp":1696263696000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1755-5922.12073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,9]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1111\/1755-5922.12073"],"URL":"https:\/\/doi.org\/10.1111\/1755-5922.12073","archive":["Portico"],"relation":{},"ISSN":["1755-5914","1755-5922"],"issn-type":[{"value":"1755-5914","type":"print"},{"value":"1755-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,9]]}}}